\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ cxr\\:\\ large\\ right\\ middle\\ mediastinal\\ mass\\ mass\\ exerting\\ mass\\ effect\\ on\\ the\\ trachea\\.\ \(0\)\
\-\ ct\\:\\ large\\ right\\ sided\\ mediastinal\\ mass\\ with\\ mass\\ effect\\ on\\ surrounding\\ vessels\\ and\\ trachea\\.\\ \\ additionally\\,\\ scattered\\ hilar\\ and\\ mediastinal\\ adenopathy\\ is\\ present\\.\\ \\ no\\ other\\ lung\\ lesions\\ seen\\.\ \(0\)\
\-\ non\\-small\\ cell\\ carcinoma\ \(3\)\
\-\ brochongenic\\ tumor\\:\\ nsclc\\ vs\\ sclc\ \(0\)\
\-\ metastatic\\ disease\\:\\ lung\\,\\ gi\\,\\ prostate\\,\\ kidney\\,\\ \\(if\\ \\ \ \(0\)\
\-\ \\ \\ \\ female\\ then\\ breast\\)\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ sarcoid\ \(163\)\
\-\ leiomyoma\\/leiomyosarcoma\\ of\\ esophagus\ \(0\)\
\-\ mesothelioma\ \(67\)\
\-\ carcinoma\\ of\\ the\\ trachea\ \(0\)\
\-\ emphysema\\ with\\ chronic\\ cough\\ and\\ weight\\ loss\\ over\\ the\\ past\\ year\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ trachea\\:\\ 0\\.14183913452970134\ \(0\)\
\-\ mediastinal\\:\\ 0\\.11337914431642947\ \(0\)\
\-\ brochongenic\\:\\ 0\\.09182831691631768\ \(0\)\
\-\ leiomyoma\\/leiomyosarcoma\\:\\ 0\\.08460803378548493\ \(0\)\
\-\ sclc\\:\\ 0\\.07738775065465216\ \(0\)\
\-\ exerting\\:\\ 0\\.0750633386617958\ \(0\)\
\-\ nsclc\\:\\ 0\\.07316415577852545\ \(0\)\
\-\ effect\\:\\ 0\\.06303246360560927\ \(0\)\
\-\ mass\\:\\ 0\\.06189901077851899\ \(0\)\
\-\ non\\-small\\:\\ 0\\.06062277240013028\ \(0\)\
\-\ mesothelioma\\:\\ 0\\.05572690126215386\ \(0\)\
\-\ lung\\:\\ 0\\.051565815004973876\ \(0\)\
\-\ carcinoma\\:\\ 0\\.05045682645866388\ \(0\)\
\-\ emphysema\\:\\ 0\\.04867066351640589\ \(0\)\
\-\ prostate\\:\\ 0\\.04727971150990044\ \(0\)\
\-\ \\:\\:\\ 0\\.04709478399961104\ \(0\)\
\-\ sarcoid\\:\\ 0\\.045673975261699834\ \(0\)\
\-\ hilar\\:\\ 0\\.04472635257205685\ \(0\)\
\-\ scattered\\:\\ 0\\.041450380385573124\ \(0\)\
\-\ gi\\:\\ 0\\.03998734043277004\ \(0\)\
\-\ adenopathy\\:\\ 0\\.03963419926948169\ \(0\)\
\-\ large\\:\\ 0\\.038927967329814156\ \(0\)\
\-\ esophagus\\:\\ 0\\.03864138489651997\ \(0\)\
\-\ additionally\\:\\ 0\\.03857844412093703\ \(0\)\
\-\ cxr\\:\\ 0\\.03756283615755289\ \(0\)\
\-\ vessels\\:\\ 0\\.035835833502940964\ \(0\)\
\-\ vs\\:\\ 0\\.03504666635834164\ \(0\)\
\-\ cough\\:\\ 0\\.034106821654250746\ \(0\)\
\-\ sided\\:\\ 0\\.03291173555361089\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.032875377168821635\ \(0\)\
\-\ breast\\:\\ 0\\.03283914524823492\ \(0\)\
\-\ middle\\:\\ 0\\.03255373926710872\ \(0\)\
\-\ weight\\:\\ 0\\.03190568526188401\ \(0\)\
\-\ then\\:\\ 0\\.03167673831689677\ \(0\)\
\-\ kidney\\:\\ 0\\.031358160990104265\ \(0\)\
\-\ surrounding\\:\\ 0\\.029262138170466304\ \(0\)\
\-\ past\\:\\ 0\\.028283327832775353\ \(0\)\
\-\ loss\\:\\ 0\\.02583816846321291\ \(0\)\
\-\ lymphoma\\:\\ 0\\.025439569108223807\ \(0\)\
\-\ chronic\\:\\ 0\\.025072808676114583\ \(0\)\
\-\ if\\:\\ 0\\.02415357743521495\ \(0\)\
\-\ cell\\:\\ 0\\.024044174078973815\ \(0\)\
\-\ lesions\\:\\ 0\\.023828755274416122\ \(0\)\
\-\ over\\:\\ 0\\.022662943647291274\ \(0\)\
\-\ metastatic\\:\\ 0\\.022407389621000938\ \(0\)\
\-\ tumor\\:\\ 0\\.02075241980844595\ \(0\)\
\-\ other\\:\\ 0\\.020517068215650504\ \(0\)\
\-\ present\\:\\ 0\\.02010425785345501\ \(0\)\
\-\ right\\:\\ 0\\.018783993939800347\ \(0\)\
\-\ female\\:\\ 0\\.018299586160914934\ \(0\)\
\-\ seen\\:\\ 0\\.01758987099028844\ \(0\)\
\-\ on\\:\\ 0\\.015081062757613084\ \(0\)\
\-\ disease\\:\\ 0\\.014549349387663585\ \(0\)\
\-\ \\,\\:\\ 0\\.014099482579025385\ \(0\)\
\-\ ct\\:\\ 0\\.01245107972283378\ \(0\)\
\-\ year\\:\\ 0\\.009959429888259527\ \(0\)\
\-\ no\\:\\ 0\\.008962959903164603\ \(0\)\
\-\ \\(\\:\\ 0\\.007524601315040213\ \(0\)\
\-\ \\)\\:\\ 0\\.007432684292846927\ \(0\)\
\-\ is\\:\\ 0\\.005857195608174225\ \(0\)\
\-\ and\\:\\ 0\\.005625281429131827\ \(0\)\
\-\ the\\:\\ 0\\.004320290146988306\ \(0\)\
\-\ with\\:\\ 0\\.0024375870018727027\ \(0\)\
\-\ of\\:\\ 0\\.0024271625166247587\ \(0\)\
\-\ \\.\\:\\ 0\\.0018489341717367852\ \(0\)\
